Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Axsome Therapeutics (AXSM) Shares Outstanding (Weighted Average): 2022-2025

Historic Shares Outstanding (Weighted Average) for Axsome Therapeutics (AXSM) over the last 4 years, with Sep 2025 value amounting to $49.9 million.

  • Axsome Therapeutics' Shares Outstanding (Weighted Average) rose 3.96% to $49.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $49.9 million, marking a year-over-year increase of 3.96%. This contributed to the annual value of $48.5 million for FY2024, which is 2.42% up from last year.
  • According to the latest figures from Q3 2025, Axsome Therapeutics' Shares Outstanding (Weighted Average) is $49.9 million, which was up 1.35% from $49.2 million recorded in Q2 2025.
  • Axsome Therapeutics' Shares Outstanding (Weighted Average)'s 5-year high stood at $49.9 million during Q3 2025, with a 5-year trough of $38.5 million in Q1 2022.
  • For the 3-year period, Axsome Therapeutics' Shares Outstanding (Weighted Average) averaged around $47.3 million, with its median value being $47.5 million (2024).
  • Data for Axsome Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY grew of 17.09% (in 2023) over the last 5 years.
  • Quarterly analysis of 4 years shows Axsome Therapeutics' Shares Outstanding (Weighted Average) stood at $43.4 million in 2022, then grew by 8.97% to $47.3 million in 2023, then grew by 2.42% to $48.5 million in 2024, then climbed by 3.96% to $49.9 million in 2025.
  • Its Shares Outstanding (Weighted Average) was $49.9 million in Q3 2025, compared to $49.2 million in Q2 2025 and $48.8 million in Q1 2025.